Amyris Acquires Oobli to Expand Sweet Proteins

The deal brings Oobli's fermentation-based sweet proteins under the Amyris family of companies.

Updated on Nov. 12, 2026 in Organic Food

Isometric editorial illustration of three tall stainless-steel fermentation vessels joined by a curved pipe on a concrete floor, one holding amber liquid.
Amyris agreed to acquire Oobli, a fermentation-based sweet-protein maker whose proteins are hundreds to thousands of times sweeter than sugar, with the deal expected to close within weeks. AI Illustration. Upload story photo >

Live Poll

Do you think the sweeteners in your food are getting healthier?

Amyris has agreed to acquire Oobli, a company that produces sweet proteins through fermentation, with the acquisition expected to close in the coming weeks. Oobli's proteins are hundreds to thousands of times sweeter than sugar and bind directly to sweet taste receptors.

Why it matters

The deal combines Oobli's sweet protein expertise with Amyris's scientific capabilities and manufacturing depth, following Amyris's recent expansion of fermentation capacity. For consumers and food makers, it signals continued growth in fermentation-derived sugar alternatives within the organic and natural food space.

Oobli's sweet proteins are produced by fermentation and are hundreds to thousands of times sweeter than sugar, according to the company. The deal's financial terms and post-close product changes were not disclosed in the source.

The players

Amyris

Amyris is a synthetic biology company that uses fermentation to produce ingredients for the food, beverage and personal care industries.

Oobli

Oobli is a company that has spent the past decade developing fermentation-based sweet proteins as sugar alternatives.

The details

Oobli's portfolio includes Oubli Fruit, Serendipity Berry and Katemfe Fruit Sweet Proteins, which carry FDA GRAS status as an ingredient and FEMA GRAS affirmation for use as a natural flavor. All existing customer commitments and brand partnerships will continue uninterrupted.

Timeline

  1. Earlier in 2026: Amyris expanded manufacturing capacity at its Barra Bonita, Brazil fermentation facility.

  2. In the coming weeks: The Oobli acquisition is expected to close.

Market Landscape

Sweet proteins that bind directly to sweet taste receptors represent a distinct approach to sugar reduction compared with conventional high-intensity sweeteners. The consolidation of Oobli into Amyris's manufacturing base reflects a broader push to scale fermentation as an alternative production route for natural sweeteners.

Consumers who buy products sweetened with Oobli's proteins should see no change in supply, as existing customer commitments will continue uninterrupted. Food makers using these ingredients can expect the same brand partnerships to remain in place after the deal closes.

The takeaway

Fermentation-based sweet proteins are moving from specialty development toward scaled manufacturing, and readers following natural sweeteners should watch how the Amyris and Oobli product lines evolve after the deal closes.

What happens next

The acquisition of Oobli by Amyris is expected to close in the coming weeks.

Further reading

For more on natural sugar alternatives, explore the Organic Food section.

Live Poll

Do you think the sweeteners in your food are getting healthier?